Trending

out-licensing

Novartis trims again with $390m drugs sale to Recordati

Novartis trims again with $390m drugs sale to Recordati

Novartis has been streamlining its business since CEO Vas Narasimhan took over, and has continued that push with

X

Novartis trims again with $390m drugs sale to Recordati

https://pharmaphorum.com/news/novartis-trims-again-with-390m-drugs-sale-to-recordati/

AZ sells anaesthetics rights to Aspen

AZ sells anaesthetics rights to Aspen

South African firm will pay $770 million.

X

AZ sells anaesthetics rights to Aspen

https://pharmaphorum.com/news/az-sell-rights-anaesthetics-pharmacare/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com